Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selegiline for Cannabis Dependence
NCT00218517Phase 2Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Mar 2005
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selegiline in cannabis use disorder (CUD), sponsored by National Institute on Drug Abuse. Started Mar 2005; status: completed.
02
Drugs
selegiline
03
Conditions
cannabis use disorder (CUD)
Beyond the preview
Go deeper on NCT00218517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00218517.